Pulmonary Fibrosis Clinical Trials

A listing of Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 66 clinical trials
Featured trial
Study to evaluate HZN-825 in patients with Idiopathic Pulmonary Fibrosis (IPF)

The goal is to determine the efficacy, safety and tolerability for 360 patients with Idiopathic Pulmonary Fibrosis (IPF) assigned to either one of 2 dose regimens of HZN-825 (administered once

emphysema
pneumonia
diffusion capacity of the lung for carbon monoxide
  • 10 views
  • 18 Oct, 2022
  • 53 locations
  • 0 views
  • 23 Oct, 2022
  • 1 location
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic Fibrosis (CF)

This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with CF who are ineligible for or unable to tolerate CFTR modulator therapy.

cftr gene
forced expiratory volume
oximetry
cystic fibrosis transmembrane conductance regulator
  • 0 views
  • 16 Oct, 2022
  • 8 locations
Low Dose Danazol for the Treatment of Telomere Related Diseases

Background DNA is a structure in the body. It contains data about how the body develops and works. Telomeres are found on the end of chromosomes in DNA. Some people with short telomeres or other gene changes can develop diseases of the bone marrow, lung, and liver. Researchers want to …

  • 76 views
  • 19 Oct, 2022
  • 1 location
The Influence of Telerehabilitation Focused on Respiratory Muscle Training

Pulmonary rehabilitation, which includes respiratory muscle training, is effective in improving the functional status of patients with various types of the respiratory system diseases, including bronchial asthma, interstitial lung diseases or lung transplant patients. However, availability of pulmonary rehabilitation is limited in the Czech Republic. Nowadays even more due to …

  • 0 views
  • 07 Oct, 2022
  • 1 location
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis (IPF). There is a 48-week randomized treatment phase followed by an optional, open-label extension phase.

idiopathic pulmonary fibrosis
pirfenidone
diffusion capacity of the lung for carbon monoxide
pamrevlumab
nintedanib
  • 67 views
  • 18 Oct, 2022
  • 127 locations
  • 23 views
  • 24 Oct, 2022
  • 228 locations
A Double Blind, Randomized, Placebo-controlled Trial Evaluating the Efficacy and Safety of BI 1015550 Over at Least 52 Weeks in Patients With Idiopathic Pulmonary Fibrosis (IPF)

This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they already take nintedanib or

idiopathic pulmonary fibrosis
pirfenidone
diffusion capacity of the lung for carbon monoxide
forced vital capacity
nintedanib
  • 0 views
  • 28 Oct, 2022
  • 5 locations
A Phase III Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis (STARSCAPE)

with idiopathic pulmonary fibrosis (IPF).

idiopathic pulmonary fibrosis
lung biopsy
diffusion capacity of the lung for carbon monoxide
6-minute walk test
nintedanib
  • 29 views
  • 24 Oct, 2022
  • 330 locations
  • 6 views
  • 23 Oct, 2022
  • 35 locations